Timolol maleate
Glaucoma · Rx
RxGlaucomaGlaucoma BetaPreservative-free option Yellow cap
| Strength | 0.25%, 0.5% |
|---|---|
| Typical quantity | 5-15 mL bottle (generic, very cheap) |
| Cash cost / month | Low · ~$0-20 |
| Drug class | Non-selective beta-blocker |
| Mechanism of action | Non-selective beta-adrenergic antagonist; reduces aqueous humour production by the ciliary epithelium. ~20-25% IOP reduction. |
| Indication / reason for use | Open-angle glaucoma and ocular hypertension; common second agent or fixed-combination partner. |
| Usual adult dosing | 1 drop once or twice daily (gel-forming and Istalol are once daily). Punctal occlusion / eyelid closure for 2 min reduces systemic absorption. |
| Preservative | BAK 0.01% (Ocudose is preservative-free) , a preservative-free option exists |
| Contact lenses | Remove lenses; reinsert after 15 minutes. BAK also accumulates in soft lenses. |
| Common / important adverse effects | Systemic beta-blockade: bradycardia, hypotension, bronchospasm, worsening heart block/CHF, fatigue, depression, reduced exercise tolerance, masking of hypoglycemia symptoms, impotence; ocular stinging, dry eye, corneal anesthesia. |
| Contraindications & cautions | Reactive airway disease / asthma / severe COPD, sinus bradycardia, 2nd/3rd-degree AV block, overt cardiac failure, cardiogenic shock. |
| Pregnancy / lactation | Beta-blocker of choice among ocular hypotensives if one is needed; monitor neonate for bradycardia if used near term. Avoid during breastfeeding or monitor infant. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Timoptic, Timoptic-XE (gel), Istalol, Betimol, Timoptic Ocudose (PF) |
| Practice notes | Least effective at night (aqueous production already low during sleep). Ask about inhalers and pulse before prescribing. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.